Advertisement
Advertisement
Trending on Dermatology Times
1
Icotrokinra Sustains Skin Clearance at High-Impact Psoriasis Sites Through 2 Years
2
EADV 2026 in Review: The Research and Therapeutic Advances That Defined the Congress
3
Dermatology Times Monthly FDA and Pipeline Review: September 2026
4
EADV 2026 Day 3: Long-Term Psoriasis Data and Emerging Therapeutic Targets Take Focus
5